Gurus BioPharm is a global leader in the development of innovative drugs based on prostaglandin modification by Nitric Oxide donor.
Our Prostaglandin & Nitric Oxide research platform binds two regulatory molecules with unique properties - prostaglandins and nitric oxide. As a result, we get multi-target (not single-target) first-in-class innovative drugs with remarkable biological activity and an excellent safety profile.Read more
GUR-701 novel drug candidate passed clinical proof of concept (PoC). It is registered as functional cosmetics, 3000+ patients are using it. The product shows amazing results and has a prospect to be #1 alopecia treatment therapy globally.
GUR-501 innovative drug candidate can be the only effective therapy for chronic patients with Asthma / COPD. It has a strong anti-inflammatory effect in the lung tissue to treat COVID-19 pneumonia.
GUR-1001 novel drug candidate can be the only glaucoma treatment medication that also cures retina ischemia.